"Doctor of Death" Trial Could Ignite Stricter Oversight in the Healthcare Industry Print E-mail
Written by George F. Indest III, JD, MPA, LLM, Health Law Board Certified   
Wednesday, 29 October 2014 18:05

On paper, one Detroit-area oncologist appeared to be a wildly successful professional with impeccable medical credentials. According to his medical practice's website, he went to medical school at Cornell Medical College, did an internal medicine residency at Maimonides Medical Center in Brooklyn, New York, and then completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center, a very well-respected facility. The oncologist ran a professional practice of seven locations with a total of 60 employees.
However, on September 24, 2014, his reputation and accolades faded when he pleaded guilty to intentionally and wrongfully diagnosing healthy patients with cancer. He also admitted to giving these patients chemotherapy solely for the purpose of making a profit.
For healthcare professionals, this act is an obvious violation of the oath they took to serve their patients and to do no harm. But, if this oncologist is found guilty, you can be assured that oncologists, physicians, dentists, and all other healthcare professionals will be under a microscope to help ensure that something this egregious and dishonest does not happen again.
Let's examine the allegations against the oncologist...

Read More>>
What happens when hospitals flip to for-profit status? Print E-mail
Written by Adrianna McIntyre | The Incidental Economist   
Friday, 24 October 2014 16:01

When for-profit Vanguard Healthcare bought the Detroit Medical Center in late 2010, worried murmurs rippled through the community. DMC is the largest provider of charity care in the state, and it wasn't clear whether Vanguard would feel obliged to honor the hospital's charitable mission-would they keep serving the uninsured, or would access and quality of care suffer? These concerns were echoed by patient advocates when Tenet Healthcare-another for-profit-acquired Vanguard in 2013, absorbing DMC in the process.

Were people right to worry? Maybe not, according to a new study published today (10.22.14) in JAMA by Karen Joynt, John Orav, and Ashish Jha.

Read More>>
Sponsor Showcase Print E-mail
Written by Sponsor   
Friday, 24 October 2014 00:00
gsk fhi-2012-ad v3
Last Updated on Friday, 24 October 2014 16:01

Website design, development, and hosting provided by